TALPHERA, INC. Adjustment to Additional Paid in Capital, Income Tax Effect from Share-based Compensation, Net
TALPHERA, INC. (TLPH) reported Adjustment to Additional Paid in Capital, Income Tax Effect from Share-based Compensation, Net of -$249.00 thousand for the 12-month period ending 2021-12-31, per its 10-K filed 2022-03-10.
Discontinued › Notes › Compensation Related Costs
us-gaap:AdjustmentToAdditionalPaidInCapitalIncomeTaxEffectFromShareBasedCompensationNet · last filed 2022-03-10
- TALPHERA, INC. adjustment to additional paid in capital, income tax effect from share-based compensation, net for the quarter ending 2021-03-31 was $249.00K, a 189.53% increase year-over-year.
- TALPHERA, INC. adjustment to additional paid in capital, income tax effect from share-based compensation, net for the quarter ending 2020-03-31 was $86.00K.
- TALPHERA, INC. adjustment to additional paid in capital, income tax effect from share-based compensation, net for fiscal 2021 was -$249.00K.
- TALPHERA, INC. adjustment to additional paid in capital, income tax effect from share-based compensation, net for fiscal 2020 was -$86.00K.
| Period end | Adjustment to Additional Paid in Capital, Income Tax Effect from Share-based Compensation, Net 2 month | Adjustment to Additional Paid in Capital, Income Tax Effect from Share-based Compensation, Net 3 month | Adjustment to Additional Paid in Capital, Income Tax Effect from Share-based Compensation, Net 3 month as first filed | Adjustment to Additional Paid in Capital, Income Tax Effect from Share-based Compensation, Net 12 month | Adjustment to Additional Paid in Capital, Income Tax Effect from Share-based Compensation, Net 12 month as first filed |
|---|---|---|---|---|---|
| 2021-12-31 | -$249.00K 10-K · filed 2022-03-10 | ||||
| 2021-03-31 | $249.00K 10-Q · filed 2021-11-15 | ||||
| 2020-12-31 | -$86.00K 10-K · filed 2022-03-10 | $86.00K 10-K · filed 2021-03-15 | |||
| 2020-03-31 | $86.00K 10-Q · filed 2021-11-15 | -$86.00K 10-Q · filed 2020-05-11 | |||
| 2020-03-01 | $86.00K 10-Q · filed 2021-05-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CalciMedica, Inc. (CALC) | United States | $0.061B | -1.42 |
| Skye Bioscience, Inc. (SKYE) | United States | $0.061B | -0.48 |
| Boundless Bio, Inc. (BOLD) | United States | $0.059B | -0.88 |
| NOMAD POWER SOLUTIONS, INC. (NMAD) | United States | $0.058B | |
| Rein Therapeutics, Inc. (RNTX) | United States | $0.063B | -1.76 |
| Annovis Bio, Inc. (ANVS) | United States | $0.056B | -1.58 |
| HYPERION DEFI, INC. (HYPD) | United States | $0.065B | |
| XBiotech Inc. (XBIT) | United States | $0.066B | -1.56 |
| HERON THERAPEUTICS, INC. /DE/ (HRTX) | United States | $0.055B | -2.38 |
| Clene Inc. (CLNN) | United States | $0.054B | -1.99 |